Poor Sleep
Sanofi India Limited and Cipla Limited have announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium®, a leading brand in the anti-epileptic medication category.
While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programs to expand access to these treatments for patients who need them.
World Asthma Day, observed on the first Tuesday of May each year, draws attention to…
A report by KPMG Assurance and Consulting Services report titled Human-Centric Approach to Tobacco Control has revealed that India loses precious…
The Department of Obstetrics and Gynaecology, AIIMS, on Saturday held a ‘Skill Enhancing Course in…
Pharma major Akums Drugs and Pharmaceuticals has introduced Amlodipine, Telmisartan & Metoprolol (ER) Film Coated…
After some media report claimed that the Food Safety and Standards Authority of India (FSSAI)…
Prof Dr Vandana Talwar, Medical Superintendent, Safdarjung Hospital, said that it is very important to…